
WB analysis of A549 cell lysate using GTX85233 OCIAD2 antibody. Working concentration : (A) 0.5 and (B) 1 microg/ml
OCIAD2 antibody
GTX85233
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry
Product group Antibodies
ReactivityHuman
TargetOCIAD2
Overview
- SupplierGeneTex
- Product NameOCIAD2 antibody
- Delivery Days Customer9
- Antibody SpecificityThis antibody is specific for OCIAD2 C-Terminus
- Application Supplier NoteWB: 0.5 - 1 microg/mL. ICC/IF: 5 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID132299
- Target nameOCIAD2
- Target descriptionOCIA domain containing 2
- Target synonymsOCIA domain-containing protein 2; ovarian cancer immunoreactive antigen domain containing 2; ovarian carcinoma immunoreactive antigen-like protein
- HostRabbit
- IsotypeIgG
- Protein IDQ56VL3
- Protein NameOCIA domain-containing protein 2
- Scientific DescriptionOCIAD2 was identified by its sequence similarity with OCIAD1, and together OCIAD1 and OCIAD2 form the OCIA domain family. OCIAD2 mRNA was found to be expressed at higher levels in invasive adenocarcinoma mixed subtype with bronchioloalveolar carcinoma component (BAC) of the lung. Loss of OCIAD2 expression was significantly correlated with lymphatic invasion, blood vessel invasion, and lymph node metastasis, indicating that OCIAD2 may play a role in cell adhesion and prevention of cell migration. While the function of OCIAD2 is still unknown, its expression in adenocarcinoma with BAC component is significantly associated with a favorable prognosis and may serve as a marker for selecting tumors that are treatable by limited surgery.
- ReactivityHuman
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203